期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 387, 期 9, 页码 860-860出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMx220007
关键词
-
This article points out incorrect data regarding the application of Darolutamide in nonmetastatic, castration-resistant prostate cancer.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246). In Table 1 (page 1239), the values provided for Presence of lymph nodes on central imaging review were incorrect. In the Darolutamide column, the values for Yes should have been 100 (10.5), rather than 163 (17), and the values for No should have been 855 (89.5), rather than 792 (83). In the Placebo column, the values for Yes should have been 66 (11.9), rather than 158 (29), and the values for No should have been 488 (88.1), rather than 396 (71). The article is correct at NEJM.org. . . .
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据